Rhabdomyolysis after taking atorvastatin with gemfibrozil

被引：93

作者：

Duell, PB ^{[1
]}

Connor, WE ^{[1
]}

Illingworth, DR ^{[1
]}

机构：

[1] Oregon Hlth Sci Univ, Dept Med, Div Endocrinol Diabet & Clin Nutr, Portland, OR 97201 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 81卷 / 03期

关键词：

D O I：

10.1016/S0002-9149(97)00907-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

引用

页码：368 / 369

页数：2

共 4 条

[1]

Duell P B, 1993, Heart Dis Stroke, V2, P260

[2] COMBINATIONS OF DRUGS IN LIPID-LOWERING THERAPY [J].

LAROSA, JC .

AMERICAN JOURNAL OF MEDICINE, 1994, 96 (05) :399-400

[3] REDUCTION OF LDL CHOLESTEROL BY 25-PERCENT TO 60-PERCENT IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA BY ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR [J].

NAWROCKI, JW ;

WEISS, SR ;

DAVIDSON, MH ;

SPRECHER, DL ;

SCHWARTZ, SL ;

LUPIEN, PJ ;

JONES, PH ;

HABER, HE ;

BLACK, DM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) :678-682

[4] MYOPATHY AND RHABDOMYOLYSIS ASSOCIATED WITH LOVASTATIN-GEMFIBROZIL COMBINATION THERAPY [J].

PIERCE, LR ;

WYSOWSKI, DK ;

GROSS, TP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (01) :71-75

← 1 →